Sethi, B., Al-Rubeaan, K., Unubol, M., Mabunay, M. A., Berthou, B., Pilorget, V., . . . Frechtel, G. D. (2022). Efficacy and Safety of Insulin Glargine 300 U/mL in People with Type 2 Diabetes Uncontrolled on Basal Insulin: The 26-Week Interventional, Single-Arm ARTEMIS-DM Study. Web
Citación estilo ChicagoSethi, Bipin, Khalid Al-Rubeaan, Mustafa Unubol, Maria A. Mabunay, Baptiste Berthou, Valerie Pilorget, Shireene R. Vethakkan, and Gustavo Daniel Frechtel. Efficacy and Safety of Insulin Glargine 300 U/mL in People With Type 2 Diabetes Uncontrolled On Basal Insulin: The 26-Week Interventional, Single-Arm ARTEMIS-DM Study. 2022.
Cita MLASethi, Bipin, et al. Efficacy and Safety of Insulin Glargine 300 U/mL in People With Type 2 Diabetes Uncontrolled On Basal Insulin: The 26-Week Interventional, Single-Arm ARTEMIS-DM Study. 2022.